Migdal Insurance & Financial Holdings’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-27,455
Closed -$702K 695
2021
Q1
$702K Buy
27,455
+17,038
+164% +$436K 0.01% 280
2020
Q4
$229K Buy
+10,417
New +$229K ﹤0.01% 302